TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell November 12, 1976
TCL Archive Oklahoma’s new cigarette tax will provide $7 million a year to the University of Oklahoma Cancer Center. November 5, 2004
